Neurogene Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 1.72 M | $39.25 M | 35.44% | 10.13% |
BLACKROCK, INC. | 02/07/2025 | 1.52 M | $34.66 M | 10.52% | 8.94% |
RTW INVESTMENTS, LP | 02/14/2025 | 1.35 M | $30.87 M | 18.94% | 7.96% |
REDMILE GROUP, LLC | 02/14/2025 | 1.32 M | $30.17 M | 36.86% | 7.78% |
CASDIN CAPITAL, LLC | 02/14/2025 | 1.30 M | $29.61 M | 146.92% | 7.64% |
ECOR1 CAPITAL, LLC | 02/14/2025 | 1.27 M | $29.06 M | 0.00% | 7.50% |
FMR LLC | 02/13/2025 | 860,333 | $19.67 M | 17.56% | 5.07% |
COMMODORE CAPITAL LP | 02/14/2025 | 800,000 | $18.29 M | 300.00% | 4.72% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 674,450 | $15.42 M | 47.90% | 3.98% |
ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 448,601 | $10.26 M | 16.08% | 2.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 448,145 | $10.24 M | 100.00% | 2.64% |
GREAT POINT PARTNERS LLC | 02/14/2025 | 442,761 | $10.12 M | -55.91% | 2.61% |
MORGAN STANLEY | 02/14/2025 | 329,863 | $7.54 M | -7.45% | 1.95% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 303,000 | $6.93 M | 1,920.00% | 1.79% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 234,625 | $5.36 M | 6.36% | 1.38% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 192,600 | $4.40 M | 100.00% | 1.14% |
NORTHERN TRUST CORP | 02/14/2025 | 100,566 | $2.30 M | 6.17% | 0.59% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 95,407 | $2.18 M | 100.00% | 0.56% |
WOODLINE PARTNERS LP | 02/14/2025 | 83,340 | $1.91 M | 0.30% | 0.49% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 80,000 | $1.83 M | 100.00% | 0.47% |
WALLEYE CAPITAL LLC | 02/13/2025 | 74,836 | $1.71 M | 68.17% | 0.44% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 74,778 | $1.71 M | 85.83% | 0.44% |
JENNISON ASSOCIATES LLC | 01/24/2025 | 72,596 | $1.66 M | -7.70% | 0.43% |
BLAIR WILLIAM & CO/IL | 02/12/2025 | 62,640 | $1.43 M | 100.00% | 0.37% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 51,500 | $1.18 M | 562.38% | 0.30% |
CITADEL ADVISORS LLC | 02/14/2025 | 38,500 | $880,110 | 100.00% | 0.23% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 32,765 | $749,008 | -67.94% | 0.19% |
UBS OCONNOR LLC | 02/14/2025 | 32,734 | $748,299 | 270.84% | 0.19% |
CITADEL ADVISORS LLC | 02/14/2025 | 31,200 | $713,232 | 100.00% | 0.18% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 27,482 | $628,239 | 0.00% | 0.16% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 26,507 | $605,950 | -34.68% | 0.16% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 21,717 | $496,451 | 18.74% | 0.13% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 20,629 | $471,579 | 100.00% | 0.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 19,000 | $434,340 | 100.00% | 0.11% |
SQUAREPOINT OPS LLC | 02/14/2025 | 17,431 | $398,473 | 250.02% | 0.10% |
02/14/2025 | 16,000 | $356,480 | 100.00% | 0.09% | |
TD ASSET MANAGEMENT INC | 02/11/2025 | 15,800 | $361,188 | 100.00% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 15,704 | $358,984 | 9.22% | 0.09% |
XTX TOPCO LTD | 02/13/2025 | 15,256 | $348,752 | 100.00% | 0.09% |
M&T BANK CORP | 02/06/2025 | 14,138 | $322,947 | 100.00% | 0.08% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 14,079 | $321,846 | 100.00% | 0.08% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 10,936 | $250,000 | 100.00% | 0.06% |
MARINER, LLC | 02/13/2025 | 10,475 | $239,459 | 100.00% | 0.06% |
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 02/12/2025 | 10,290 | $239,037 | 72.77% | 0.06% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 10,100 | $230,886 | 100.00% | 0.06% |
HRT FINANCIAL LP | 02/14/2025 | 9,933 | $227,000 | 100.00% | 0.06% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 9,189 | $210,060 | -71.87% | 0.05% |
CITIGROUP INC | 02/12/2025 | 8,100 | $185,166 | 8.55% | 0.05% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 5,924 | $135,423 | 4.00% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 5,121 | $117,066 | -7.01% | 0.03% |
Neurogene Inc. institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Neurogene Inc.. The most heavily invested institutionals were:
Samsara BioCapital, LLC: 1.72 M
BlackRock, Inc.: 1.52 M
RTW INVESTMENTS, LP: 1.35 M
Redmile Group, LLC: 1.32 M
Casdin Capital, LLC: 1.3 M
EcoR1 Capital, LLC: 1.27 M
93.57% of Neurogene Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.40 M shares in the last 24 months. This purchase volume represents approximately $163.70 M in transactions.